|
|||||
|
|
NPC-0501 trial on the value of changing chemoradiotherapy sequence,replacing 5-fluorouracil with capecitabine,and altering fractionation for patients with advanced nasopharyngeal carcinoma |
|
| Authors: | Anne W. M. Lee MD Roger K. C. Ngan FRCR Wai-Tong Ng MD Stewart Y. Tung FRCR Ashley A. C. Cheng FRCR Dora L. W. Kwong MD Tai-Xiang Lu MD Anthony T. C. Chan MD Henry C. K. Sze FRCR Harry H. Y. Yiu FRCR Frank C. S. Wong FRCR Kam-Tong Yuen FRCR Rick Chappell PhD Horace C. W. Choi PhD |
| Affiliation: | 1. Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Guangdong, China;2. Department of Clinical Oncology, The University of Hong Kong, Hong Kong, Hong Kong Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong;3. Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong;4. Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, Hong Kong;5. Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong, Hong Kong;6. Department of Clinical Oncology, The University of Hong Kong, Hong Kong, Hong Kong Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, Hong Kong;7. Department of Clinical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China;8. Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong;9. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong;10. Department of Biostatistics, University of Wisconsin Medical School, Madison, Wisconsin, USA;11. Department of Clinical Oncology, The University of Hong Kong, Hong Kong, Hong Kong |
| Abstract: | |
| Keywords: | accelerated fractionation capecitabine chemoradiotherapy nasopharyngeal carcinoma randomized controlled trial |